+検索条件
-Structure paper
タイトル | An experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody. |
---|---|
ジャーナル・号・ページ | mBio, Vol. 15, Issue 1, Page e0247723, Year 2024 |
掲載日 | 2024年1月16日 |
著者 | Kristina E Atanasoff / Luca Brambilla / Daniel C Adelsberg / Shreyas Kowdle / Christian S Stevens / Stefan Slamanig / Chuan-Tien Hung / Yanwen Fu / Reyna Lim / Linh Tran / Robert Allen / Weina Sun / J Andrew Duty / Goran Bajic / Benhur Lee / Domenico Tortorella / |
PubMed 要旨 | The COVID-19 pandemic remains a significant public health concern for the global population; the development and characterization of therapeutics, especially ones that are broadly effective, will ...The COVID-19 pandemic remains a significant public health concern for the global population; the development and characterization of therapeutics, especially ones that are broadly effective, will continue to be essential as severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) variants emerge. Neutralizing monoclonal antibodies remain an effective therapeutic strategy to prevent virus infection and spread so long as they recognize and interact with circulating variants. The epitope and binding specificity of a neutralizing anti-SARS-CoV-2 Spike receptor-binding domain antibody clone against many SARS-CoV-2 variants of concern were characterized by generating antibody-resistant virions coupled with cryo-EM structural analysis and VSV-spike neutralization studies. This workflow can serve to predict the efficacy of antibody therapeutics against emerging variants and inform the design of therapeutics and vaccines. |
リンク | mBio / PubMed:38054729 / PubMed Central |
手法 | EM (単粒子) |
解像度 | 2.53 - 3.16 Å |
構造データ | EMDB-28537, PDB-8eqf: EMDB-29227: cryoEM structure of a broadly neutralizing antibody STI-9167 |
由来 |
|
キーワード | IMMUNE SYSTEM (免疫系) / antibody (抗体) / SARS-CoV-2 (SARSコロナウイルス2) |